345 related articles for article (PubMed ID: 11863320)
1. Efficacy of a single-dose ondansetron for preventing post-operative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane and remifentanil infusion anaesthesia.
Paventi S; Santevecchi A; Ranieri R
Eur Rev Med Pharmacol Sci; 2001; 5(2):59-63. PubMed ID: 11863320
[TBL] [Abstract][Full Text] [Related]
2. Induction with sevoflurane-remifentanil is comparable to propofol-fentanyl-rocuronium in PONV after laparoscopic surgery.
Yang H; Choi PT; McChesney J; Buckley N
Can J Anaesth; 2004; 51(7):660-7. PubMed ID: 15310632
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone plus ondansetron for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a comparison with dexamethasone alone.
Bano F; Zafar S; Aftab S; Haider S
J Coll Physicians Surg Pak; 2008 May; 18(5):265-9. PubMed ID: 18541078
[TBL] [Abstract][Full Text] [Related]
4. Tropisetron vs ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomized double-blind, placebo-controlled study.
Argiriadou H; Papaziogas B; Pavlidis T; Parlapani A; Georgiou M; Papagiannopoulou P; Papaziogas T
Surg Endosc; 2002 Jul; 16(7):1087-90. PubMed ID: 12165828
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
[TBL] [Abstract][Full Text] [Related]
6. Ondansetron in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a prospective randomized study.
So JB; Cheong KF; Sng C; Cheah WK; Goh P
Surg Endosc; 2002 Feb; 16(2):286-8. PubMed ID: 11967679
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy.
Elhakim M; Nafie M; Mahmoud K; Atef A
Can J Anaesth; 2002 Nov; 49(9):922-6. PubMed ID: 12419717
[TBL] [Abstract][Full Text] [Related]
8. Fast-track anaesthesia for laparoscopic cholecystectomy: a prospective, randomized, multicentre, blind comparison of desflurane-remifentanil or sevoflurane-remifentanil.
Fanelli G; Berti M; Casati A
Eur J Anaesthesiol; 2006 Oct; 23(10):861-8. PubMed ID: 16723051
[TBL] [Abstract][Full Text] [Related]
9. Prevention of post-operative nausea and vomiting in children--a prospective randomized double-blind study.
Sakellaris G; Georgogianaki P; Astyrakaki E; Michalakis M; Dede O; Alegakis A; Makatounaki K; Charissis G
Acta Paediatr; 2008 Jun; 97(6):801-4. PubMed ID: 18460109
[TBL] [Abstract][Full Text] [Related]
10. Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies.
Quaynor H; Raeder JC
Acta Anaesthesiol Scand; 2002 Jan; 46(1):109-13. PubMed ID: 11903083
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for nausea and vomiting following vitrectomy in adults.
Nitahara K; Sugi Y; Shono S; Hamada T; Higa K
Eur J Anaesthesiol; 2007 Feb; 24(2):166-70. PubMed ID: 16978442
[TBL] [Abstract][Full Text] [Related]
12. The effect of premedication with OTFC, with or without ondansetron, on postoperative agitation, and nausea and vomiting in pediatric ambulatory patients.
Binstock W; Rubin R; Bachman C; Kahana M; McDade W; Lynch JP
Paediatr Anaesth; 2004 Sep; 14(9):759-67. PubMed ID: 15330959
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of postoperative nausea and vomiting with ondansetron, metoclopramide, or placebo in total intravenous anesthesia patients undergoing laparoscopic cholecystectomy.
Kaki AM; Abd El-Hakeem EE
Saudi Med J; 2008 Oct; 29(10):1408-13. PubMed ID: 18946563
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol plus ondansetron prevents postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
Feng PH; Chu KS; Lu IC; Shieh JP; Tzeng JI; Ho ST; Wang JJ; Chu CC
Acta Anaesthesiol Taiwan; 2009 Mar; 47(1):3-9. PubMed ID: 19318293
[TBL] [Abstract][Full Text] [Related]
15. Effects of remifentanil infusion bis-titrated on early recovery for obese outpatients undergoing laparoscopic cholecystectomy.
Paventi S; Santevecchi A; Perilli V; Sollazzi L; Grio M; Ranieri R
Minerva Anestesiol; 2002 Sep; 68(9):651-7. PubMed ID: 12370681
[TBL] [Abstract][Full Text] [Related]
16. Supplemental 80% oxygen does not attenuate post-operative nausea and vomiting after breast surgery.
Purhonen S; Niskanen M; Wüstefeld M; Hirvonen E; Hynynen M
Acta Anaesthesiol Scand; 2006 Jan; 50(1):26-31. PubMed ID: 16451147
[TBL] [Abstract][Full Text] [Related]
17. Intravenous, oral, and the combination of intravenous and oral ramosetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, controlled trial.
Ryu JH; Jeon YT; Hwang JW; Oh AY; Moon JY; Ro YJ; Kim CS; Chen C; Apfel CC; Do SH
Clin Ther; 2011 Sep; 33(9):1162-72. PubMed ID: 21856001
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of orally disintegrating ondansetron in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomised, double-blind placebo controlled study.
Grover VK; Mathew PJ; Hegde H
Anaesthesia; 2009 Jun; 64(6):595-600. PubMed ID: 19453311
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of ondansetron in the prevention of nausea and vomiting after laparoscopic cholecystectomy].
Cabrera JC; Matute E; Escolano F; Castillo J; Santiveri X; Castaño J
Rev Esp Anestesiol Reanim; 1997 Jan; 44(1):36-8. PubMed ID: 9148349
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of postoperative nausea and vomiting with single and repeat administration of ondansetron--review of the literature on different administration forms].
Saur P; Mühr C; Kazmaier S; Neumann P; Buhre W
Anaesthesiol Reanim; 1996; 21(5):131-5. PubMed ID: 9044556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
